Healthcare Delivery · NSE · period ending 2026-03-31
Loading chart…
✓ Core business is permissible and non-compliant income is 2.1% of revenue (limit 5%).
| Ratio | Value | Limit | Result |
|---|---|---|---|
| Debt / 36-month avg market cap | 0% | < 33% | Pass |
| Cash + interest-bearing securities / 36-month avg market cap | 0% | < 33% | Pass |
| Accounts receivable / 36-month avg market cap | 0% | < 33% | Pass |
The underlying figures and the filing citations they came from are available with a free account.
Sign up free2.1% of any dividend from MEDANTA should be given to charity. Calculate your amount →
Moderately positive 3–6 month returns with a small positive 1-month, but the 50-day is below the 200-day and price is over 13% off its 52-week high, indicate a recovering stock transitioning from prior weakness. The improving returns point to an emerging uptrend not yet fully reflected in longer-term structure.
Computed from delayed price history and desk sentiment. Educational context only — not investment advice or a price prediction.
Compliance watch: verdict re-verified against live market cap on 13 Jun 2026 · rechecked every 6 hours · filings reviewed quarterly.